MedTrace Logo

A Study of Male Rectal Samples in Preparation for Future Rectal Microbicide Trials

NCT00075062 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2008-08-21

No results posted yet for this study

Summary

Microbicides are drugs that destroy microbes such as viruses and bacteria. Rectal microbicides may be able to prevent transmission of HIV during anal intercourse. The purpose of this study is to obtain rectal samples from men to learn information that may be valuable in future clinical trials of rectal microbicides.

Conditions

  • HIV Infections
  • HIV Seronegativity

Interventions

PROCEDURE

Flexible Sigmoidoscopy

PROCEDURE

Rectal Biopsy

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Ian McGowan, MD, PhD · University of California, Los Angeles

  • Peter Anton, MD · University of California, Los Angeles

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00075062 on ClinicalTrials.gov